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Abstract
Staphylococcus aureus is an important human pathogen in both hospital and the community that has demonstrated
resistance to all currently available antibiotics over the last two decades. Multidrug-resistant isolates of methicillin-resistant
S. aureus (MRSA) exhibiting decreased susceptibilities to glycopeptides has also emerged, representing a crucial challenge
for antimicrobial therapy and infection control. The availability of complete whole-genome nucleotide sequence data of
various strains of S. aureus presents an opportunity to explore novel compounds and their targets to address the challenges
presented by antimicrobial drug resistance in this organism. Study compounds a-amyrin [3b-hydroxy-urs-12-en-3-ol (AM)],
betulinic acid [3b-hydroxy-20(29)-lupaene-28-oic acid (BA)] and betulinaldehyde [3b-hydroxy-20(29)-lupen-28-al (BE)]
belong to pentacyclic triterpenoids and were reported to exhibit antimicrobial activities against bacteria and fungi,
including S. aureus. The MIC values of these compounds against a reference strain of methicillin-resistant S. aureus (MRSA)
(ATCC 43300) ranged from 64 mg/ml to 512 mg/ml. However, the response mechanisms of S. aureus to these compounds are
still poorly understood. The transcription profile of reference strain of MRSA treated with sub-inhibitory concentrations of
the three compounds was determined using Affymetrix GeneChips. The findings showed that these compounds regulate
multiple desirable targets in cell division, two-component system, ABC transporters, fatty acid biosynthesis, peptidoglycan
biosynthesis, aminoacyl-tRNA synthetase, ribosome and b-lactam resistance pathways which could be further explored in
the development of therapeutic agents for the treatment of S. aureus infections.
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Introduction
Antibiotic resistance is a growing global threat to the effective
treatment of infectious diseases. Over the past two decades
resistance has been reported in many clinically important
pathogens and to a broad range of antimicrobials in clinical use
today [1,2,3]. This has been the driving force for the discovery of
novel agents with antimicrobial activity that may potentially lead
to therapeutic agents. The isolation of vancomycin, b-lactam,
macrolide, tetracycline, aminoglycoside and quinolone-resistant
strains of S. aureus provides a message that the availability of
structurally novel antibacterials with multiple modes of action
need to be part of the antibacterial armamentarium [4]. Over the
past 30 years, only two new classes of antibiotics for the treatment
of staphylococcal infections have been introduced: the oxazolidi-
nones represented by linezolid, and the lipopeptide daptomycin
[5]. However, reports of resistance to these antibiotics have also
been reported [6]. Clearly, new approaches and innovative
strategies are required to discover and identify agents that target
essential bacterial targets in novel pathways, i.e. not targeted by
currently used antibiotics, or novel targets in existing pathways.
Promising targets for novel antibacterials against S. aureus include
cell division, DNA replication and biosynthesis of fatty acid,
peptidoglycan and protein [7].
To capture and exploit the wealth and diversity of genetic
information of a variety of microorganisms, development of new
technologies such as microarray provides a unique tool to
understand the molecular basis of drug activity as it allows
simultaneous analysis of the expression of all genes in the organism
under any given condition. Transcriptional profiles generated by
GeneChip analysis of bacteria have been used to investigate
differential gene expression in response to antimicrobial agents [8],
such as the response of S. aureus strain 8325-4 to antibiotics that act
on cell wall such as oxacillin, D-cycloserine and bacitracin [9], and
the effects of vancomycin on gene expression in S. aureus [10].
Plant-derived natural products have been reported to show anti-
staphylococcal activities with micromolar MICs
[11,12,13,14,15,16]. In a preliminary study, the effects of 191
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extracts towards different strains of bacteria were evaluated.
Extracts from Callicarpa farinosa were shown to exhibit strong
antimicrobial activities against MRSA [16]. Three pentacyclic
triterpenoids, namely a-amyrin, betulinic acid and betulinalde-
hyde, have been investigated and found to have antibacterial
activity against reference strains of methicillin-sensitive and
methicillin-resistant S. aureus. Their activity was potentiated by
currently used antistaphylococcal drugs [17]. In this study, the
genome-wide transcription induced by the exposure of reference
strain of S. aureus to pentacyclic triterpenoids was used to elucidate
the mechanism of action of the compounds.
Materials and Methods
Bacterial Strains and Materials
The S. aureus strain used in this study was reference strain
ATCC 43300, representing methicillin-resistant strains. The
bacterial strain was maintained on Nutrient Agar (NA) (Difco,
USA) slopes. Bacterial cultures used for microarray experiments
were grown on cation-adjusted Mueller-Hinton broth (CAMHB
II) (Difco, USA). Commercial sources of pentacyclic triterpenoids
a-amyrin (AM) and betulinic acid (BA) were obtained from Sigma-
Aldrich (USA), while betulinaldehyde (BE) was obtained from
Advanced Technology and Industrial Co., Ltd (Hong Kong).
Growth of Staphylococcus aureus in the Presence of AM,
BA and BE
In order to obtain good microarray results, the concentrations
of the compounds need to be optimized at sub-inhibitory
concentrations that do not affect the growth of the organism
[18,19,20,21]. The treatment time with AM, BA and BE was
determined by exposure of the organism to the study compounds
and bacterial growth curve analysis. The bacterial culture was
grown in CAMHB and incubated at 37uC with shaking at
200 rpm, to an optical density of 0.3 at 600 nm; i.e. at mid-
logarithmic phase as culture conditions at this phase were most
constant and RNA levels were at the highest due to high metabolic
rate. The optical density of the cultures was measured using a
spectrophotometer (Nanophotometer, Germany). The cultures
were then distributed into 100 ml aliquots. AM, BA and BE were
added to the aliquots to obtain concentrations of 1/26 MIC
(32 mg/ml for AM and BA; 256 mg/ml for BE) and 16 MIC
(64 mg/ml for AM and BA; 512 mg/ml for BE) [17]. The cultures
were then incubated, and cell growth was spectrophotometrically
monitored at OD 600 nm for 5 hours at time intervals of 30
minutes. Untreated bacterial culture was used as control. The
growth curve for each treatment and concentration was carried
out in triplicates.
Total RNA Isolation and Purification
Three independent bacterial cultures for each treatment and
control were prepared as biological replicates for total RNA
isolation. After treatment of bacterial cells with the study
compounds at concentrations and incubation times as determined
from the growth curve, the cells were immediately stabilized with
RNA Protect Bacteria Reagent (Qiagen, USA) to minimize RNA
degradation before harvesting. Total RNA was isolated from
treated and control bacterial cultures using the RNeasy Midikit
(Qiagen) protocol. The cell wall of S. aureus was disrupted with
Tris-EDTA (TE) buffer with 50 mg/ml lysozyme (Sigma Aldrich)
containing proteinase K (Qiagen). DNA was removed using
RNase-free DNase I (Qiagen). After purification, RNA concen-
tration was determined by absorbance at 260 nm on Nanophot-
ometer (1 absorbance unit is equivalent to 40 mg/ml RNA). RNA
integrity was determined using Agilent RNA 6000 Nano chips
(Agilent Technologies, USA). The procedure in preparing the
assay, loading the chip and running the assay was carried out
according to the manufacturer’s protocol at Malaysia Genome
Institute, Bangi, Malaysia.
The total RNA analysis showed that the A260/A280 and A260/
A230 readings of all the total RNA samples were in the range of 1.8
to 2.1 and a single peak at 260 nm indicating that the samples
were free from contaminants such as proteins, phenol and salts,
which could interfere with down-stream applications such as
cDNA synthesis and microarray analysis. The RIN values were
above 7.0, indicative of non-degraded RNA (supporting informa-
tion Table S1).
cDNA Synthesis, Fragmentation and Terminal Labeling
cDNA was synthesized with a starting material of 10 mg of the
total RNA, according to manufacturer’s protocol (prokaryotic
array, Affymetrix, USA). The procedure was carried out in a
Mastercycler Gradient thermal cycler (Eppendorf, Germany). The
cDNA obtained was then purified using a MinElute PCR
Purification Column Kit (Qiagen) and quantified using Nano-
photometer at 260 nm absorbance. A minimum of 1.5 mg cDNA
was then fragmented in a reaction mix containing DNase I and
DNase running buffer (Promega, USA). The fragmented cDNA
was then applied directly to the terminal labeling reaction using
GeneChip DNA Labeling Reagent (Affymetrix). The fragmented
and labeled cDNA (target) was then used for hybridization.
GeneChip Hybridization
The labeled fragmented cDNA from independent RNA
preparations were hybridized onto a Genechip probe array
masked with known genome of S. aureus N315 (methicillin-resistant
strain), Mu50 (methicillin and vancomycin-resistant strain), COL
(methicillin-resistant strain) and NCTC 8325 strains (methicillin-
sensitive strain) (Affymetrix). The array contains probe sets of over
3300 S. aureus ORFs and over 4800 intergenic regions throughout
the S. aureus genome. The labeled cDNA was hybridized, washed
and scanned according to manufacturer’s protocol (prokaryotic
array, Affymetrix). The data obtained was analyzed using the
Affymetrix GeneChip Command Console software (AGCC).
Microarray Analysis
For gene expression analysis, data from the Affymetrix platform
were processed with GeneSpring version 11 software. Data was
normalized to minimize systematic non-biological differences to
reveal true biological differences. Significance analysis using
ANOVA test with multiple testing correction Benjamini Hochberg
to correct false discovery rate and asymptotic p-value computation
was performed to determine the change of expression of a
particular gene due to the effect of different treatment on S. aureus.
In addition, fold-change analysis was also performed and reported
as the up- or down-regulated fold change. To select the
differentially expressed genes, threshold values of $2 fold-change
between pentacyclic triterpenoid-treated samples and control
samples and significance level of ,5% were used. From the
statistical analysis, the gene ontology (GO) analysis was carried
out. The pathways affected by the differentially expressed genes
were analyzed using the KEGG database (http://www.genome.
jp/kegg/pathway.html). To group genes with similar expression
profiles together, hierarchical clustering analysis was used in which
an entity tree and a condition tree were generated.
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Validation of Gene Expression by Quantitative Real-time
Quantitative PCR
To determine the validity of the microarray data, transcript
level changes obtained with the microarray analysis were
compared with those from quantitative real-time PCR (qPCR).
Aliquots of cDNA preparations used in the microarray experi-
ments were used for qPCR procedure. A list of genes and the
primer sequences used for the real-time PCR analysis is shown in
Table 1. The housekeeping gene adhE and gyrA were used as
endogenous reference genes. The procedure was performed using
the iCycler iQ5 Real Time PCR Detection System (Bio-Rad
Laboratories, USA) with Quantitect SYBR Green PCR kit
(Qiagen). For each gene, three biological replicates with three
technical replicates each were used. Real-time cycler conditions
were carried out according to manufacturer’s protocol: initial
activation step at 95uC for 15 min, followed by 45 cycles of
denaturation at 15 s and 94uC, annealing at 30 s and 53 to 60uC
(as optimized for each target gene, data not shown), and extension
at 30 s and 72uC. Melting curve analysis was also performed to
verify PCR specificity. PCR efficiencies were derived from
standard curve slopes in the iCycler software v3.1. Relative
quantification based on the relative expression of the target gene
compared to reference genes adhE and gyrA in treated and control
samples was used to determine transcript level changes [22].
Paired student’s T test was performed to assess whether the means
of a treated and control group (samples) is significantly different
from each other using the SPSS software (PASW Statistic 18).
Results and Discussion
Growth Profile of Staphylococcus aureus in the Presence
of AM, BA and BE
The effect of AM, BA and BE on the growth of reference strain
of MRSA is as shown in Figure 1. The growth rate of the organism
decreased at concentrations K MIC and MIC after 30 min for
AM; and 45 min for BA and BE. After 300 min, the growth of the
organism at K MIC was generally higher than the growth at
MIC. These effects of the growth indicates that AM, BA and BE
are bacteriostatic compounds as reported by Chung et al. [17].
Based on the growth curves, the organism was then treated with
the three study compounds atKMIC (32 mg/ml for AM and BA;
and 256 mg/ml for BE) and further incubated for 30 min (control
and treatment with AM) and 45 min (treatment with BA and BE).
Subinhibitory concentrations of the compounds were used in the
microarray procedure to avoid secondary responses caused by
high concentrations of the compounds.
Overview of Transcriptional Profiles of Staphylococcus
aureus Treated with Pentacyclic Triterpenoids
From the data processed using GeneSpring version 11 software,
an enormous number of genes were significantly differentially
regulated (p,0.05, fold change $2) in response to treatment with
AM, BA and BE as compared to control (Table 2). For example, a
total of 1265 genes were significantly affected in the treatment of
reference methicillin-resistant strains with BE. There is also a vast
number of the genes which are uncharacterized, without specific
functional category and pathways, and with unknown function
(Tables S2, S3).
Overall, the changes in expression levels of most genes were
moderate with ratio in the range of 2- to 3-fold (Tables 3, 4, 5, 6).
There are 31 genes coding for ribosome which were highly down-
regulated (more than 5-fold and up to 21-fold), indicating that
ribosome assembly may play a prominent role in the response of S.
aureus to BE. Four genes in the fatty acid biosynthesis and three
genes in the peptidoglycan biosynthesis were down-regulated more
than 3-fold while three genes in the ABC transporters were at least
3-fold up-regulated after treatment with BE. ABC transporters and
ribosomes are significantly regulated by all three pentacyclic
triterpenoids. Only BE affects cell division, while only BA targets
genes in b-lactam resistance and DNA replication pathways.
Differentially expressed genes in promising pathways such as
cell division (ftsZ), ABC transporters (opp-1C), biosynthesis of fatty
acid (fabZ), peptidoglycan (fmhB, pbp2) and protein (asnC), DNA
replication (ccrA) and b-lactam resistance (mecR1) were selected to
be validated by real-time PCR. The paired student’s T test analysis
showed that all these selected genes were extremely statistically
significantly different between bacterial cells treated with AM, BA
or BE, and untreated cells. The difference in the expression of
reference genes adhE and gyrA was considered not significantly
different (Table S4).
Table 1. Primers used in real-time PCR for validation of target genes.
Gene
symbol
Sequence
accession
number Amplicon length Primer sequence
Forward Reverse
ftsZ 1123860 85 AGCTGCAGAGGAATCTCGTGAACA TCCGCCACCCATACCAGAAGTA
opp-1C 1125181 81 CGTGCGTGTGATGTTATGTTGGCA TTCGGCACCCATTCCAAACAATGC
oppF 1122975 81 GGTGGGCAACGTCAGCGTGTAA GGACACTGCCTCGTCGCAAACA
asnC 1124125 120 TCGGTGGATCTGAACGTGTGGA GTGGCACACTACCATAACGACG
fabZ 1124802 131 TGAAGAAGGTCAACGTTGTGTGGC CCGCACCTGTTTGAGCTAACGC
fmhB 1124980 151 AAGCGAGGTACGACAGTAGAACG CATCTCCATCTTCATGCAACGCA
pbp2 1124121 90 CGTTTCTACGAACATGGCGCAC GGCACCTTCAGAACCAAATCCACCA
ccrA 1122832 106 CAGCTTGGCCGAACTTGAATCAGA ACCAAAGGGCGCATGGGTTG
mecR1 1122813 112 GTGCTCGTCTCCACGTTAATTCCA GACTAACCGAAGAAGTCGTGTCAG
adhE 1122918 105 TTAGCGAAGTCGAACCGAACCCA CTGAACCACCACCAAGTGCAATGA
gyrA 1122777 80 TATCCGCTTGTTGATGGCCAAGG CGCGCTTCAGTATAACGCATTGC
doi:10.1371/journal.pone.0056687.t001
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A comparison of genes identified in the treatments of all three
study compounds showed that genes rpmG and kdpA, which code
for the protein of the large subunit 50S and potassium-
transporting ATPase subunit A, respectively, are down-regulated.
AM and BA showed up-regulation of opp-1C in the ABC
transporter pathway, while kdpE in the two-component systems
are similarly down-regulated in BA and BE. Treatment of the
bacterial strain with AM and BE affected the highest number of
similarly regulated genes, involving a total of seven genes in the
two-component systems, fatty acid biosynthesis, peptidoglycan
biosynthesis, aminoacyl-tRNA biosynthesis and ribosome path-
ways (Table 7). Generally, all three study compounds acted on
more than one target/pathway that is unique to the microorgan-
isms. This is a highly desirable property of an antibacterial agent
and it could potentially delay the development of bacterial
resistance to the compounds [23,24].
Validation of Gene Expression by qPCR
The target genes selected for validation represent significant
pathways in S. aureus identified as promising targets in the
literature, and two genes selected as reference genes because they
were not differentially regulated by AM, BA and BE. The target
genes were ftsZ (cell division), opp-1C and oppF (ABC transporters),
asnC (aminoacyl-tRNA biosynthesis), fabZ (fatty acid biosynthesis),
fmhB and pbp2 (peptidoglycan biosynthesis), ccrA (DNA replication),
and mecR1 (b-lactam resistance), while the reference genes were
adhE (metabolism of fatty acid and glycolysis) and gyrA (DNA
replication). All the target and reference genes validated showed
single peaks in melting curves, indicating the amplification of
specific amplicons (data not shown). The high specificity of the
reactions was further confirmed by the single band and size of the
amplicons observed in the agarose gel electrophoresis (Figure 2).
The expression of the target genes was quantified using the relative
quantification method which measures the changes in the
expression of the target genes in response to the different
treatment normalized to the expression of reference gene(s). The
expression of genes opp-1C, oppF, asnC and mecR1 was observed at
greater fold-change by real-time PCR than with microarray
analysis. For three other genes fabZ, fmhB and ccrA, the levels of
gene expression did not differ markedly between the microarray
data and real-time PCR analysis. Genes ftsZ and pbp2 showed
higher gene expression level in microarray analysis. The compar-
ison of the gene expression level by qPCR and microarray analysis
is shown in Table 8.
Novel Pathways Targeted by AM, BA and BE
Cell division. BE inhibits genes encoding proteins FtsZ and
FtsA in the cell division process of the bacterial cell. FtsZ is an
essential division protein and forms a ring structure that recruits
further cell division proteins. Cell division starts with the
polymerization of FtsZ into the Z ring, which is the heart of the
division apparatus and serves as a landing pad for the recruitment
of other proteins to the division site. Suppression of FtsZ prevents
Figure 1. Growth curves of reference strain of methicillin-
resistant Staphylococcus aureus treated with a-amyrin, betulinic
acid and betulinaldehyde.
doi:10.1371/journal.pone.0056687.g001
Table 2. Total number of differentially regulated genes in response to a-amyrin, betulinic acid and betulinaldehyde.
Treatment Up-regulated genes Down-regulated genes Total number of significantly regulated genes
a-amyrin 77 102 179
Betulinic acid 178 69 247
Betulinaldehyde 523 742 1265
doi:10.1371/journal.pone.0056687.t002
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cell division, leading to mass increase and eventually cell lysis.
Even if inhibition of division does not result in cell death, it should
prevent proliferation of the bacteria within the host and the spread
of bacteria from infection sites, thus enhancing the efficiency of
host-defense factors [25]. FtsA which tethers FtsZ to the
membrane, recruits downstream divisome proteins and stabilizes
Table 3. Selected genes which are differentially up-regulated in response to a-amyrin, betulinic acid and betulinaldehyde.
N315 ORF Gene symbol Product Fold changed Functional category
(A) Treatment with a-amyrin
ABC transporters
SA2253 opp-1C Oligopeptide transporter permease +2.1 Transport and binding proteins
(B) Treatment with betulinic acid
ABC transporters
SA2253 opp-1C Oligopeptide transporter permease +2.1 Transport and binding proteins
b-lactam resistance
SA0039 mecR1 Methicillin resistance protein +2.1 Transcription
DNA replication
SA0057 ccrB Cassette chromosome recombinase B +2.2 DNA replication
SA0058 ccrA Cassette chromosome recombinase A +2.4 DNA replication
(C) Treatment with betulinaldehdye
Two component system
SAS066 agrD AgrD protein +2.1 Signal transduction mechanisms
Aminoacyl-tRNA biosynthesis
SA0986 pheT Phenylalanine-tRNA synthetase beta chain +3.0 Translation
ABC transporters
SA0109 sirC Lipoprotein (iron complex transport protein) +2.6 Inorganic ion transport
SA0110 sirB Lipoprotein (iron complex transport protein) +5.8 Inorganic ion transport
SA0198 oppF Oligopeptide transport ATP-binding protein +3.8 Inorganic ion transport
SA1214 opp2B Oligopeptide transporter permease +3.5 Inorganic ion transport
doi:10.1371/journal.pone.0056687.t003
Table 4. Selected genes which are differentially down-regulated in response to a-amyrin.
N315 ORF Gene symbol Product Fold changed Functional category
Two-component system
SA0661 saeR Response regulator 23.9 Regulatory function
SA0060 saeS Histidine protein kinase 22.2 Regulatory function
SA1881 kdpA Potassium-transporting ATPase subunit A 22.6 Inorganic ion transport
SA1936 luxS S-ribosylhomocysteinasae 22.1 Signal transduction
Aminoacyl-tRNA biosynthesis
SA0488 cysS Cysteinyl-tRNA synthetase 22.1 Translation
SA1106 proS Prolyl-tRNA synthetase 22.6 Translation
SA1287 asnC Asparaginyl-tRNA synthetase 22.4 Translation
SA1506 thrS Threonyl-tRNA synthetase 22.4 Translation
Fatty acid biosynthesis
SA1073 fabD Malonyl coA-acyl carrier protein transacylase 22.5 Fatty acid and phospholipid metabolism
Peptidoglycan biosynthesis
SA2057 fmhB FmhB protein 22.2 Cell envelope
Ribosome
SAS042 rpmG 50s ribosomal protein L33 22.0 Transcription
SA0354 rpsR 30s ribosomal protein S18 22.1 Transcription
SA0497 rplJ 50s ribosomal protein L10 22.5 Transcription
doi:10.1371/journal.pone.0056687.t004
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Z rings at membrane. Thus, suppression of FtsZ and FtsA proteins
inhibits growth and could exert bactericidal effect [26].
Two-component system. From the microarray analysis,
AM, BA and BE have the potential to target the virulence factors
of MRSA, which includes structures that promote adhesion,
colonization and dissemination; the components responsible for
cell communication and regulatory functions; the factors that
facilitate evasion of the immune system; and the machineries for
toxin production and excretion [27]. Expression of these factors is
regulated by a range of global regulators comprising two-
component regulatory systems which are sensitive to environmen-
tal signals [28,29,30]. The study compounds regulates three of the
systems of the 16 two-component systems identified by genomic
scans in S. aureus, i.e. Agr, Sae and Kdp.
The expression of gene agrD and inhibition of agrA, as observed
in the treatment with BE, leads to the decreased production of
capsule, toxins and proteases, thus decreasing the virulence of the
organism. AM which inhibits saeR and saeS also decreases
virulence as a result of reduction in the production in several
exoproteins and cell-bound proteins involved in pathogenicity
[31]. With the inhibition of kdpA and kdpE as observed in the
treatment with BA and BE, the transcription of genes encoding
cell wall proteins and polysaccharides, which are beneficial to
colonization, are repressed [32]. As a result, the virulence of the
organism is reduced with the exposure to each of the compounds.
ABC transporters. The up-regulation of oligopermease
transporter oppC by AM and BA, and oppF by BE may increase
the efficient transport of peptides for the salvage of essential amino
acids from the environment of the bacterial cell. The uptake of
these peptides could be to compensate for the halt in protein
synthesis due to the inhibition of the aminoacyl-tRNA synthetase
and ribosomes. The up-regulation of gene sirB as observed in the
treatment with BE, indicates there could be an uptake of iron (III)-
staphylobactin to satisfy its requirement for iron, which is an
essential micronutrient for bacteria and serves as the catalytic
center of enzymes involved in critical cellular processes such as
DNA synthesis and electron transport [33]. This may represent an
attempt by the organism to acquire iron for successful establish-
ment of infection, as a response to the environmental stress caused
by BE.
Novel Targets in Existing Pathways Regulated by AM, BA
and BE
Fatty acid biosynthesis. BE down-regulates a group of
genes in the type II fatty acid synthesis (FAS) pathway, which
include genes encoding for enzymes that are involved in the
assembly of important cellular components in the bacteria, such as
phospholipids, lipoproteins, lipopolysaccharides, myolic acids and
the cell envelope [34]. The inhibition of enzymes encoded by fabF,
fabI, fabD, fabG and fabZ may cause modification of the
permeability of the phospholipid bilayer and destabilization of
the cell membrane. As a result, processes such as passive transport
of hydrophobic molecules, active transport of solutes and protein-
protein interactions could be affected [35]. Thus, AM and BE may
be able to enter the cells relatively easier via passive transport.
However, due to the high partition coefficients of AM and BE at
log P values of 11.01 and 9.07, respectively (Chemspider database,
http://www.chemspider.com/Search.aspx), the entry of these
compounds may still not increase significantly, thus the high
observed MIC values at 64 and 512 mg/ml as compared to current
anti-staphylococcal agents such as methicillin and vancomycin.
Peptidoglycan biosynthesis. Closely linked to cell division
is peptidoglycan synthesis. Coordinated synthesis of the peptido-
glycan is crucial for the integrity of the bacterial cell, attachment
sites for virulence factors and resistance to external stress
conditions [36]. BE inhibits three mur genes (murA, murC and
murG), fmhB and pbp2 which are involved in the synthesis initiation
phase, modification, and polymerization and cross-linking of lipid
II, respectively. The suppression of the synthesis of lipid II which is
the substrate for Pbp2 and transpeptidation reactions results in the
weakening of the peptidoglycan, leading to cell lysis and death.
The majority of approved anti-staphylococcal drugs that target the
peptidoglycan biosynthesis act on extracellular steps and resistance
to these drugs are on the rise. An attractive alternative is to exploit
the intracellular steps, involving the mur and fem genes. There are
currently no known antibiotics or synthetic chemicals of thera-
peutic usefulness that inhibits the Mur enzymes, except for MurA
which is inhibited by fosfomycin [37].
Aminoacyl-tRNA biosynthesis. The suppression of six
aminoacyl-tRNA synthetase, namely cysS, proS, asnC, thrS, serS
and lysS, by AM and BE causes the accumulation of the deacylated
form of tRNA. The shortage of corresponding aminoacyl-tRNA of
a required amino acid prompts the stringent response with
increased levels of guanosine tetraphosphates (ppGpp) and
guanosine pentaphosphates (pppGpp). RNA polymerase is inhib-
ited, thus directly reducing the production of RNA. This leads to
subsequent inhibition of all key downstream cellular processes such
as the biosynthesis of protein and peptidoglycan [38]. By
perturbing several metabolically important processes, the inhibi-
tion of aminoacyl-tRNA synthetase leads to the cessation of
bacterial growth and the attenuation of virulence in vivo [39].
Ribosome. The assembly of the ribosome begins with the
transcription of rRNA [40] and proceeds through the synthesis of
ribosomal proteins [41]. In comparison to the other study
compounds, BE inhibits the expression of the highest number of
genes in the ribosome, with 13 and 23 of the 30S and 50S
Table 5. Selected genes which are differentially down-regulated in response to betulinic acid.
N315 ORF Gene symbol Product Fold changed Functional category
Two component system
SA1883 kdpE KDP operon transcriptional regulatory protein 22.1 Signal transduction mechanisms
SA0068 kdpA Potassium-transporting ATPase subunit A 22.1 Signal transduction mechanisms
ABC transporters
SA0198 oppF Oligopeptide transport ATP-binding protein 22.2 Inorganic ion transport
Ribosome
SAS042 rpmG 50s ribosomal protein L33 22.1 Transcription
doi:10.1371/journal.pone.0056687.t005
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Table 6. Selected genes which are differentially down-regulated in response to betulinaldehyde.
N315 ORF Gene symbol Product Fold changed Functional category
Cellular process
SA1029 ftsZ Cell division protein FtsZ 24.8 Cell division
SA1028 ftsA Cell division protein FtsA 25.2 Cell division
Two-component system
SA1844 agrA Accessory gene regulator A 22.4 Signal transduction mechanisms
SA1881 kdpA Potassium-transporting ATPase subunit A 29.0 Signal transduction mechanisms
SA1883 kdpE KDP operon transcriptional regulatory protein 22.7 Signal transduction mechanisms
Aminoacyl-tRNA biosynthesis
SA0209 serS Seryl-tRNA synthetase 22.7 Translation
SA0475 lysS Lysyl-tRNA synthetase 23.3 Translation
SA1106 proS Propyl-tRNA synthase 22.3 Translation
SA1287 asnC Asparaginyl-tRNA synthase 22.3 Translation
SA1506 thrS Threonyl-tRNA synthase I 22.6 Translation
Fatty acid biosynthesis
SA0843 fabF 3-oxoacyl synthase 23.4 Fatty acid and phospholipid metabolism
SA0889 fabI Enoyl-(acyl carrier protein) reductase 22.7 Fatty acid and phospholipid metabolism
SA1073 fabD Malonyl coA-acyl carrier protein transacylase 23.0 Fatty acid and phospholipid metabolism
SA1074 fabG 3-oxoacyl-{acyl-carrier protein} reductase 23.9 Fatty acid and phospholipid metabolism
SA1901 fabZ (3R)-hydroxymyristoyl ACP dehydratase 23.7 Fatty acid and phospholipid metabolism
Peptidoglycan biosynthesis
SA1251 murG Undecaprenyldiphospho-muramoylpentapeptide beta-N-
acetylglucosaminyltransferase
23.9 Cell envelope
SA1283 pbp2 Penicillin binding protein 2 24.5 Cell envelope
SA1561 murC UDP-N-acetylmuramate L-alanine ligase 22.5 Cell envelope
SA1902 murA UDP-N-acetylglucoasmine 1-carboxyvinyltransferase 25.1 Cell envelope
SA2057 fmhB FmhB protein 22.2 Cell envelope
Ribosome
SA0503 rpsL 30S ribosomal protein S12 27.3 Translation
SA2025 rpsM 30S ribosomal protein S13 26.1 Translation
SA1081 rpsP 30S ribosomal protein S16 22.9 Translation
SA2038 rpsQ 30S ribosomal protein S17 210.2 Translation
SA0354 rpsR 30S ribosomal protein S18 24.8 Translation
SA2043 rpsS 30S ribosomal protein S19 24.8 Translation
SA1099 rpsB 30S ribosomal protein S2 29.9 Translation
SA1414 rpsT 30S ribosomal protein S20 26.6 Translation
SA1404 rpsU 30S ribosomal protein S21 212.9 Translation
SAS052 rpsD 30S ribosomal protein S4 25.7 Translation
SA0496 rplA 50S ribosomal protein L1 26.1 Translation
SA2031 rpsE 30S ribosomal protein S5 28.3 Translation
SA0352 rpsF 30S ribosomal protein S6 25.7 Translation
SA0497 rplJ 50S ribosomal protein L10 26.5 Translation
SA0495 rplK 50S ribosomal protein L11 26.2 Translation
SA2017 rplM 50S ribosomal protein L13 29.0 Translation
SA2037 rplN 50S ribosomal protein L14 29.2 Translation
SA2029 rplO 50S ribosomal protein L15 26.3 Translation
SA2040 rplP 50S ribosomal protein L16 27.4 Translation
SA2022 rplQ 50S ribosomal protein L17 23.7 Translation
SA2032 rplR 50S ribosomal protein L18 27.6 Translation
SA1473 rplU 50S ribosomal protein L21 26.9 Translation
SA2036 rplX 50S ribosomal protein L24 29.7 Translation
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subunits, respectively. The compounds could bind to the precursor
forms of rRNA and ribosomal proteins and stall the normal
assembly sequence of the ribosome. As a result, continued
translation could be reduced, leading to inhibition of protein
synthesis and prevention of growth of the bacteria. The
interference with the assembly of the ribosomal subunit from its
constituent rRNA and proteins could be a new target for inhibition
of antibacterial agents.
b-lactam resistance. MecA, the main determinant for
methicillin resistance, is inducible and modulated by a signal-
transduction system encoded by genes from the SCCmec [42],
which comprises a sensor/signal transducer MecR1, and a
transcriptional repressor, methicillin repressor MecI [43]. Treat-
ment with BA causes the expression of gene mecR1 that results in
the production of fully functional MecR1 and MecI that appear to
repress the production of pbp2a [44,45]. The observation indicates
that BA could be modified and developed into a more potent
Table 7. Similarly regulated genes in response to treatment with a-amyrin, betulinic acid and/or betulinaldehyde.
N315 ORF Gene symbol Product Pathway
Treatment with a-amyrin, betulinic acid and betulinaldehyde
SA1881 kdpA Potassium-transporting ATPase subunit A Two-component system
SAS042 rpmG 50s ribosomal protein L33 1,2,3 Ribosome
Treatment with a-amyrin and betulinic acid
SA1881 kdpA Potassium-transporting ATPase subunit A Two-component system
SA2253 opp-1C Oligopeptide transporter permease ABC transporter
SAS042 rpmG 50s ribosomal protein L33 1,2,3 Ribosome
Treatment with a-amyrin and betulinaldehyde
SA1881 kdpA Potassium-transporting ATPase subunit A Two-component system
SA1287 asnC Asparaginyl-tRNA synthase Aminoacyl-tRNA biosynthesis
SA1073 fabD Malonyl coA-acyl carrier protein transacylase Fatty acid biosynthesis
SA2057 fmhB FmhB protein Peptidoglycan biosynthesis
SA0354 rpsR 30s ribosomal protein S18 Ribosome
SA0497 rplJ 50s ribosomal protein L10 Ribosome
SAS042 rpmG 50s ribosomal protein L33 1,2,3 Ribosome
Treatment with betulinic acid and betulinaldehyde
SA1881 kdpA Potassium-transporting ATPase subunit A Two-component system
SA1883 kdpE KDP operon transcriptional regulatory protein Two-component system
SAS042 rpmG 50s ribosomal protein L33 1,2,3 Ribosome
doi:10.1371/journal.pone.0056687.t007
Table 6. Cont.
N315 ORF Gene symbol Product Fold changed Functional category
SA0459 rplY 50S ribosomal protein L25 25.4 Translation
SA1471 rpmA 50S ribosomal protein L27 26.3 Translation
SA1067 rpmB 50S ribosomal protein L28 26.3 Translation
SA2039 rpmC 50S ribosomal protein L29 29.4 Translation
SA2047 rplC 50S ribosomal protein L3 24.9 Translation
SA2030 rpmD 50S ribosomal protein L30 26.2 Translation
SA1922 rpmE 50S ribosomal protein L31 type B 24.8 Translation
SAS033 rpmF 50S ribosomal protein L32 27.7 Translation
SAS042 rpmG 50S ribosomal protein L33 1,2,3 28.4 Translation
SAS093 rpmH 50S ribosomal protein L34 26.3 Translation
SA1503 rpmI 50S ribosomal protein L35 26.0 Translation
SAS078 rpmJ 50S ribosomal protein L36 221.0 Translation
SA2035 rplE 50S ribosomal protein L5 26.3 Translation
SA0498 rplL 50S ribosomal protein L7/L12 28.3 Translation
SA0014 rplI 50S ribosomal protein L9 22.8 Translation
doi:10.1371/journal.pone.0056687.t006
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inhibitor of penicillin-binding protein (PBP) that can target
MRSA. In addition, BA has the potential to restore the in vitro
activity of b-lactams and glycopeptides against MRSA, as shown
in the strong synergistic interactions with methicillin and
vancomycin [17].
Conclusions
Microbial genomics has allowed the identification of a greater
number of desirable and essential antibacterial targets for further
evaluation. From the transcriptional profile, AM, BA and BE
regulate multiple desirable targets in essential pathways which
Table 8. Comparison of gene expression level by quantitative real-time PCR and microarray analysis.
N315 ORF Gene name# Product Fold change
Real-time PCR Microarray
SA1029 ftsZ(3) Cell division protein 22.2 24.8
SA2253 opp-1C(1) Oligopeptide transporter permease +3.4 +2.1
SA0198 oppF(3) Oligopeptide transport ATP-binding protein +3.4 +2.2
SA1287 asnC(1) Asparaginyl-tRNA synthetase 27.4 22.4
SA1901 fabZ(3) (3R)-hydroxymyristoyl ACP dehydratase 23.1 23.7
SA2057 fmhB(1) FmhB protein 22.1 22.2
SA1283 pbp2(3) Penicillin-binding protein 2 23.1 24.5
SA0058 ccrA(2) Cassette chromosome recombinase A +2.7 +2.4
SA0039 mecR1(2) Methicillin resistance protein +5.9 +2.1
#Treatment of bacterial cell with pentacyclic triterpenoids:
(1)a-amyrin,
(2)betulinic acid,
(3)betulinaldehyde.
doi:10.1371/journal.pone.0056687.t008
Figure 2. Agarose gel electrophoresis of PCR product.
doi:10.1371/journal.pone.0056687.g002
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could be further explored in the development of therapeutic agents
for the treatment of S. aureus infections. In addition, the structure of
the study compounds differ from the currently used anti-
staphylococcal agents, and thus cross-resistance is unlikely and
development of resistance to these novel compounds will be
delayed. While the compounds have the ability to affect multiple
and essential targets, the relatively high MICs in S. aureus suggests
that the permeability of the compounds into the bacterial cell may
not be optimum and compound modifications may be required to
improve the permeability. A more detailed examination of these
gene responses is also needed to further characterize the
antimicrobial action of each of the regulated pathways.
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